Cargando…
Hydroxychloroquine/chloroquine and azithromycin in COVID-19 patients: prospective study of electrical parameters
Autores principales: | Ammor, Othmane, Ait Brik, Abdessamad, El Boussaadani, Badre, Mahdi, Zainab, Najdi, Adil, Raissuni, Zainab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Cardiología.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486069/ http://dx.doi.org/10.1016/j.rccl.2020.09.002 |
Ejemplares similares
-
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022) -
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
por: Bakadia, Bianza Moise, et al.
Publicado: (2021) -
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
por: Tian, Ai-Ling, et al.
Publicado: (2021) -
THE CONSEQUENCES OF THE LOCKDOWN ON CARDIOVASCULAR DISEASES
por: Aajal, Assia, et al.
Publicado: (2021) -
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling
por: Rowland Yeo, Karen, et al.
Publicado: (2020)